💨 Abstract
Ionis Pharmaceuticals Inc. reported a Q1 loss of $147 million, with a loss of 93 cents per share, beating Wall Street expectations. The revenue was $132 million, also exceeding forecasts. Ionis expects full-year revenue between $725 million and $750 million. The results were generated by Automated Insights using data from Zacks Investment Research.
Courtesy: wtop.com
Suggested
Charlie Smyth’s game-winner for Saints is ‘dream scenario’ for Northern Irish kicker -
Jakub Dobes stops 27 shots in the Canadiens’ 4-1 victory over the Oilers -
Winning numbers drawn in Sunday’s Virginia Cash Pop -
Jacob Cofie’s 21 points, 10 rebounds help USC beat Washington State 68-61 -
Rams WR Davante Adams might not be ready for Seahawks showdown after reinjuring hamstring vs Lions -
Murphy, Fears lead Pelicans past Bulls 114-104 for second straight win -
Warriors coach Kerr laments shooting at Brown, calls again for common-sense gun control laws -
Two people have been found dead inside a Los Angeles home owned by actor-director Rob Reiner, source tells AP -
2 people found dead in home owned by Rob Reiner, AP source says -
La generación Z impulsa la venta de discos de vinilo, pero la razón no es solo el sonido -